Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Li, Hongbin ^a   Li, Guoshun ^a   Zhao, Xinyu ^a   Wu, Yongkang ^a   Ma, Wen ^a   Liu, Yuling ^a   Gong, Fengming ^a   Liang, Shufang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Autoimmune hepatitis; Isobaric tags for relative and absolute quantification (iTRAQ); Serum proteomics

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; COMPLEMENT COMPONENT C3; FUMARYLACETOACETASE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 17F; SERUM AMYLOID A; SERUM AMYLOID A1; SERUM AMYLOID A2; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN; PEPTIDE; PLASMA PROTEIN; PROTEOME;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEPATITIS; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOLOGY; BLOOD; CHEMISTRY; COMPUTER PROGRAM; DISEASE MODEL; ISOTOPE LABELING; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ALPHA-MACROGLOBULINS; AMINO ACID SEQUENCE; ANIMALS; BLOOD PROTEINS; COMPLEMENT C3; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SOFTWARE;

EID: 84878814448     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-146     Document Type: Article

References (42)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006, 354:54-66. 10.1056/NEJMra050408, 16394302.
2. Chung H, Watanabe T, Kudo M, Maenishi O, Wakatsuki Y, Chiba T. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int 2010, 30:222-231. 10.1111/j.1478-3231.2009.02092.x, 19650840.
3. Xia Q, Lu F, Yan HP, Wang HX, Feng X, Zhao Y, Liu BY, Wang J, Li P, Xue Y. Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis. J Proteome Res 2008, 7:1963-1970. 10.1021/pr700861s, 18355017.
4. Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol 2011, 55:171-182. 10.1016/j.jhep.2010.12.012, 21167232.
5. Vierling JM. Diagnosis and treatment of autoimmune hepatitis. Curr Gastroenterol Rep 2012, 14:25-36. 10.1007/s11894-011-0236-2, 22179843.
6. Song Q, Liu G, Hu S, Zhang Y, Tao Y, Han Y, Zeng H, Huang W, Li F, Chen P. Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. J Proteome Res 2009, 9:30-39.
7. Ballot E, Bruneel A, Labas V, Johanet C. Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin Chem 2003, 49:634-643. 10.1373/49.4.634, 12651817.
8. Huguet S, Labas V, Duclos-Vallee JC, Bruneel A, Vinh J, Samuel D, Johanet C, Ballot E. Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis. Proteomics 2004, 4:1341-1345. 10.1002/pmic.200300757, 15188401.
9. Lu F, Xia Q, Ma Y, Yuan G, Yan H, Qian L, Hu M, Wang M, Lu H, Wang H. Serum proteomic-based analysis for the identification of a potential serological marker for autoimmune hepatitis. Biochem Bioph Res Co 2008, 367:284-290.
10. Tahiri F, Le Naour F, Huguet S, Lai-Kuen R, Samuel D, Johanet C, Saubamea B, Tricottet V, Duclos-Vallee JC, Ballot E. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology 2008, 47:937-948. 10.1002/hep.22149, 18306218.
11. Zingaretti C, Cardaci A, Moro M, Crosti M, Sinisi A, Sugliano E, Cheroni C, Marabita F, Nogarotto R, Bonnal RJP. Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteomics 2012, 11:1885-1897. 10.1074/mcp.M112.018713, 22997428.
12. Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol 2000, 32:181-197.
13. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperon 2005, 10:86-103.
14. Liang S, Shen G. Biomarkers of glioma. Molecular Targets of CNS Tumors 2011, 325-342. InTech Press, Garami M, Available from: http://www.intechopen.com/articles/show/title/biomarkers-of-gliomaISBN 978-953-307-736-9.
15. Anderson NL, Anderson NG. The human plasma proteome history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867. 10.1074/mcp.R200007-MCP200, 12488461.
16. Christen U, Holdener M, Hintermann E. Animal models for autoimmune hepatitis. Autoimmun Rev 2007, 6:306-311. 10.1016/j.autrev.2006.04.001, 17412303.
17. Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, Guan W, Yuan YS, Gao J. Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J Gastroenterol 2012, 18:119-125. 10.3748/wjg.v18.i2.119, 3257438, 22253517.
18. Gong F, Liang S, He C, Shen G, Xu Y. The optimized conditions of two dimensional polyacrylamide gel electrophoresis for serum proteomics. J Proteomics Bioinform 2008, 1:250-257.
19. Tarr AW, Urbanowicz RA, Ball JK. The role of humoral innate immunity in hepatitis C virus infection. Viruses 2012, 4:1-27. 10.3390/v4010001, 3280516, 22355450.
20. Schiødt FV, Ostapowicz G, Murray N, Satyanarana R, Zaman A, Munoz S, Lee WM. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transplant 2006, 12:1776-1781.
21. Liu FC, Chang DM, Lai JH, Lin CK, Chen HC, Hou TY, Kuo SY. Autoimmune hepatitis with raised alpha-fetoprotein level as the presenting symptoms of systemic lupus erythematosus: a case report. Rheumatol Int 2007, 27:489-491. 10.1007/s00296-006-0242-0, 17047958.
22. Aparicio JL, Peña C, Retegui LA. Autoimmune hepatitis-like disease in C57BL/6 mice infected with mouse hepatitis virus A59. Int Immunopharmacol 2011, 11:1591-1598. 10.1016/j.intimp.2011.05.020, 21635973.
23. Hardtke-Wolenski M, Taubert R, Jaeckel E. Animal models of autoimmune liver disease-What is relevant for immune-mediated liver disease?. Dig Dis 2012, 14(1):2-10.
24. Molina H, Perkins SJ, Guthridge J, Gorka J, Kinoshita T, Holers VM. Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules. J Immunol 1995, 154:5426-5435.
25. Shariat-Madar Z, Schmaier AH. Review: the plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsis. J Endotoxin Res 2004, 10:3-13.
26. Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, Gaupp S, Rump LC, Gold R. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA 2009, 106:14942-14947. 10.1073/pnas.0903602106, 2736426, 19706425.
27. Liang S, Xu Z, Xu X, Zhao X, Huang C, Wei Y. Quantitative proteomics for cancer biomarker discovery. Comb Chem High T Scr 2012, 15:221-231.
28. Tunstall A, Merriman J, Milne I, James K. Normal and pathological serum levels of alpha2-macroglobulins in men and mice. J Clin Pathol 1975, 28:133-139. 10.1136/jcp.28.2.133, 475612, 47865.
29. Chen M, Daha MR, Kallenberg CGM. The complement system in systemic autoimmune disease. J Autoimmun 2010, 34:J276-J286. 10.1016/j.jaut.2009.11.014, 20005073.
30. Flierl MA, Gaudiani JL, Sabel AL, Long CS, Stahel PF, Mehler PS. Complement C3 serum levels in anorexia nervosa: a potential biomarker for the severity of disease?. Ann Gen Psychiatry 2011, 10:10-16. 10.1186/1744-859X-10-10, 3090384, 21463526.
31. Hussain N, Jaffery G, Hasnain S. Serum complement C3 and C4 levels in relation to diagnosis of lupus nephritis. Trop J Pharm Res 2008, 7:1117-1121.
32. James K, Merriman J, Gray R, Duncan L, Herd R. Serum alpha 2-macroglobulin levels in diabetes. J Clin Pathol 1980, 33:163-166. 10.1136/jcp.33.2.163, 1146013, 6154066.
33. Gao X, Liu H, Ding G, Wang Z, Fu H, Ni Z, Ma J, Liu F, Fu Z. Complement C3 deficiency prevent against the onset of streptozotocin-induced autoimmune diabetes involving expansion of regulatory T cells. Clin Immunol 2011, 104:236-243.
34. Laarman AJ, Ruyken M, Malone CL, Van Strijp JAG, Horswill AR, Rooijakkers SHM. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J Immunol 2011, 186:6445-6453. 10.4049/jimmunol.1002948, 21502375.
35. Tu Z, Li Q, Chou HS, Hsieh CC, Meyerson H, Peters MG, Bu H, Fung JJ, Qian S, Lu L. Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis. Immunobiology 2011, 216:528-534. 10.1016/j.imbio.2010.08.004, 3557916, 20851495.
36. White IR, Patel K, Symonds WT, Dev A, Griffin P, Tsokanas N, Skehel M, Liu C, Zekry A, Cutler P. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. J Transl Med 2007, 5:33-41. 10.1186/1479-5876-5-33, 1971245, 17625010.
37. Vasudev NS, Ferguson RE, Cairns DA, Stanley AJ, Selby PJ, Banks RE. Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?. Proteomics 2008, 8:5074-5085. 10.1002/pmic.200800497, 19003870.
38. Zhou J, Liang S, Fang L, Chen L, Tang M, Xu Y, Fu A, Yang J, Wei Y. Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS 2009, 13:93-103. 10.1089/omi.2008.0075, 19207037.
39. Liang S, Xu Y, Shen G, Liu Q, Zhao X, Xu Z, Xie X, Gong F, Li R, Wei Y. Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis 2009, 30:4152-4162. 10.1002/elps.200900249, 19960480.
40. Unwin RD, Griffiths JR, Whetton AD. Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS. Nat Protoc 2010, 5:1574-1582. 10.1038/nprot.2010.123, 21085123.
41. Chong PK, Lee H, Zhou J, Liu SC, Loh MCS, Wang TT, Chan SP, Smoot DT, Ashktorab H, So JBY. ITIH3 is a potential biomarker for early detection of gastric cancer. J Proteome Res 2010, 9:3671-3679. 10.1021/pr100192h, 20515073.
42. Ogata Y, Charlesworth MC, Higgins LA, Keegan BM, Vernino S, Muddiman DC. Differential protein expression in male and female human lumbar cerebrospinal fluid using iTRAQ reagents after abundant protein depletion. Proteomics 2007, 7:3726-3734. 10.1002/pmic.200700455, 17853512.